German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

[1]  H. Dralle,et al.  Benefit-Risk Balance of Reoperation for Persistent Medullary Thyroid Cancer , 2013, Annals of surgery.

[2]  M. Kreissl,et al.  Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. , 2013, Thyroid : official journal of the American Thyroid Association.

[3]  H. Dralle,et al.  Prognostic Impact of N Staging in 715 Medullary Thyroid Cancer Patients: Proposal for a Revised Staging System , 2013, Annals of surgery.

[4]  H. Dralle,et al.  Surgical management of the lateral neck compartment for metastatic thyroid cancer , 2013, Current opinion in oncology.

[5]  H. Dralle,et al.  Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  R. Valcavi,et al.  Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. , 2012, Thyroid : official journal of the American Thyroid Association.

[7]  A. Pinchera,et al.  Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[8]  D. Cooper,et al.  Prophylactic central neck dissection in differentiated thyroid cancer: a procedure in search of an indication. , 2012, Thyroid : official journal of the American Thyroid Association.

[9]  L. Bastholt,et al.  2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer , 2012, European Thyroid Journal.

[10]  H. Dralle,et al.  Biological relevance of medullary thyroid microcarcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  M. Pelizzo,et al.  Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. , 2012, The Journal of clinical endocrinology and metabolism.

[12]  A. Bockisch,et al.  Feinnadelbiopsie (FNB) der Schilddrüse , 2012, Der Nuklearmediziner.

[13]  A. Agha,et al.  Completion Thyroidectomy: Effect of Timing on Clinical Complications and Oncologic Outcome in Patients With Differentiated Thyroid Cancer , 2012, World Journal of Surgery.

[14]  Hang-Seok Chang,et al.  Skip Lateral Neck Node Metastases in Papillary Thyroid Carcinoma , 2012, World Journal of Surgery.

[15]  Yong-xue Zhu,et al.  Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. , 2012, The Journal of clinical endocrinology and metabolism.

[16]  A. Pinchera,et al.  The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  H. Min,et al.  BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer , 2012, World Journal of Surgery.

[18]  S. Franceschi,et al.  Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. , 2012, Thyroid : official journal of the American Thyroid Association.

[19]  G. Barbesino,et al.  Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up. , 2011, Thyroid : official journal of the American Thyroid Association.

[20]  J. Ricarte-Filho,et al.  Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. , 2011, Thyroid : official journal of the American Thyroid Association.

[21]  S. Carty,et al.  American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. , 2011, Thyroid : official journal of the American Thyroid Association.

[22]  P. Peduzzi,et al.  American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[23]  H. Moch,et al.  Poorly Differentiated Thyroid Carcinomas: How Much Poorly Differentiated is Needed? , 2011, The American journal of surgical pathology.

[24]  M. Ladanyi,et al.  BRAF Mutation Analysis of Fine-Needle Aspiration Biopsies of Papillary Thyroid Carcinoma: Impact on Diagnosis and Prognosis , 2011, Acta Cytologica.

[25]  S. Asa,et al.  Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation , 2011, Modern Pathology.

[26]  Douglas B. Evans.  Papillary carcinoma of the thyroid: balancing principles of oncology with emerging technology. , 2011, Surgery.

[27]  J. Shah,et al.  The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. , 2011, Surgery.

[28]  Kevin Ro,et al.  A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. , 2011, Surgery.

[29]  M. Luster,et al.  Radioiodine for remnant ablation and therapy of metastatic disease , 2011, Nature Reviews Endocrinology.

[30]  Herb Chen,et al.  Should All Papillary Thyroid Microcarcinomas Be Aggressively Treated?: An Analysis of 18,445 Cases , 2011, Annals of surgery.

[31]  J. Lew,et al.  Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. , 2011, Journal of the American College of Surgeons.

[32]  R. Tuttle,et al.  Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer , 2011, Clinical endocrinology.

[33]  T. Uruno,et al.  Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[34]  A. Miyauchi,et al.  Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. , 2011, Thyroid : official journal of the American Thyroid Association.

[35]  M. Rodier,et al.  The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. , 2011, The Journal of clinical endocrinology and metabolism.

[36]  T. Yen,et al.  Prevalence and significance of thyroid uptake detected by 18F-FDG PET , 2011, Endocrine.

[37]  P. Birner,et al.  Incidental Papillary Microcarcinoma of the Thyroid—Further Evidence of a Very Low Malignant Potential: A Retrospective Clinicopathological Study With Up to 30 Years of Follow-Up , 2011, Annals of Surgical Oncology.

[38]  C. Nies,et al.  German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease , 2011, Langenbeck's Archives of Surgery.

[39]  Juan Rosai,et al.  A large multicenter correlation study of thyroid nodule cytopathology and histopathology. , 2011, Thyroid : official journal of the American Thyroid Association.

[40]  Paul G Gauger,et al.  The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. , 2011, Thyroid : official journal of the American Thyroid Association.

[41]  C. Hsueh,et al.  Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. , 2011, Surgical oncology.

[42]  V. Fendrich,et al.  Calcitonin-Secreting Pancreatic Endocrine Tumors: Systematic Analysis of a Rare Tumor Entity , 2011, Pancreas.

[43]  N. Morgenthaler,et al.  Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. , 2011, Clinical chemistry.

[44]  C. O'Neill,et al.  Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[45]  P. Chiarelli,et al.  Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: A literature review , 2011, Head & neck.

[46]  Jeong Goo Kim,et al.  Analysis of the Clinicopathologic Features of Papillary Thyroid Microcarcinoma Based on 7-mm Tumor Size , 2011, World Journal of Surgery.

[47]  S. Devesa,et al.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. , 2011, Thyroid : official journal of the American Thyroid Association.

[48]  H. Moon,et al.  Minimal Extrathyroidal Extension in Patients with Papillary Thyroid Microcarcinoma: Is It a Real Prognostic Factor? , 2011, Annals of Surgical Oncology.

[49]  C. Sekulla,et al.  Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence, and cancer-specific survival. , 2010, Surgery.

[50]  R. Burney,et al.  Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. , 2010, Surgery.

[51]  A. Chou,et al.  BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. , 2010, Surgery.

[52]  R. Kloos.  Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. , 2010, The Journal of clinical endocrinology and metabolism.

[53]  K. Lorenz,et al.  Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. , 2010, The Journal of pediatrics.

[54]  R. Garberoglio,et al.  Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. , 2010, Thyroid : official journal of the American Thyroid Association.

[55]  J. Ricarte-Filho,et al.  Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. , 2010, Thyroid : official journal of the American Thyroid Association.

[56]  K. Schmid,et al.  Familiäre Karzinome der Schilddrüse , 2010, Der Pathologe.

[57]  M. Hirokawa,et al.  Prognostic Impact of Extrathyroid Extension and Clinical Lymph Node Metastasis in Papillary Thyroid Carcinoma Depend on Carcinoma Size , 2010, World Journal of Surgery.

[58]  B. Niederle,et al.  High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel. , 2010, The Journal of clinical endocrinology and metabolism.

[59]  Han-Sin Jeong,et al.  Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections. , 2010, Surgery.

[60]  A. Gill,et al.  Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms. , 2010, Surgery.

[61]  P. Vitti,et al.  Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. , 2010, The Journal of clinical endocrinology and metabolism.

[62]  T. Fahey,et al.  Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. , 2010, Human pathology.

[63]  Puneeth Iyengar,et al.  Hodgkin lymphoma involving extranodal and nodal head and neck sites , 2010, Cancer.

[64]  Byung-Joo Lee,et al.  Clinical Implication of the Number of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: Preliminary Report , 2010, World Journal of Surgery.

[65]  B. Ljung,et al.  Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine-needle Aspiration Biopsy , 2010, World Journal of Surgery.

[66]  V. Bernet.  Approach to the patient with incidental papillary microcarcinoma. , 2010, The Journal of clinical endocrinology and metabolism.

[67]  Q. Duh,et al.  Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. , 2010, Surgery.

[68]  C. Sekulla,et al.  Management of lymph fistulas in thyroid surgery , 2010, Langenbeck's Archives of Surgery.

[69]  T. Fahey,et al.  Prophylactic Central Neck Dissection and Local Recurrence in Papillary Thyroid Cancer: A Meta-analysis , 2010, Annals of Surgical Oncology.

[70]  M. Guerrero,et al.  Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. , 2010, American journal of surgery.

[71]  H. Dralle,et al.  Decreasing tumor size of thyroid cancer in Germany: institutional experience 1995-2009. , 2010, European journal of endocrinology.

[72]  H. Dralle,et al.  Biomarker-based risk stratification for previously untreated medullary thyroid cancer. , 2010, The Journal of clinical endocrinology and metabolism.

[73]  K. Schmid,et al.  Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. , 2010, European journal of endocrinology.

[74]  U. Beutner,et al.  Diagnosis and treatment of small follicular thyroid carcinomas , 2010, The British journal of surgery.

[75]  M. Xing,et al.  Prognostic utility of BRAF mutation in papillary thyroid cancer , 2010, Molecular and Cellular Endocrinology.

[76]  E. Larrañaga,et al.  [Metastasis in the thyroid gland]. , 2010, Cirugia espanola.

[77]  B. Niederle,et al.  Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid. , 2010, Thyroid : official journal of the American Thyroid Association.

[78]  Madhavi Tripathi,et al.  Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography , 2010, Annals of nuclear medicine.

[79]  F. Trimarchi,et al.  Thyroid Metastases from Renal Cell Carcinoma: Review of the Literature , 2010, TheScientificWorldJournal.

[80]  T. Fahey,et al.  Impact of Prophylactic Central Neck Lymph Node Dissection on Early Recurrence in Papillary Thyroid Carcinoma , 2010, World Journal of Surgery.

[81]  E. Morgen,et al.  The role of fine-needle aspiration in the diagnosis of thyroid lymphoma: a retrospective study of nine cases and review of published series , 2010, Journal of Clinical Pathology.

[82]  E. Choi,et al.  Occult lymph node metastases in neck level V in papillary thyroid carcinoma. , 2010, Surgery.

[83]  M. Guerrero,et al.  Age and tumor size predicts lymph node involvement in Hürthle Cell Carcinoma , 2010, Journal of Cancer.

[84]  M. Hirokawa,et al.  Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. , 2010, Thyroid : official journal of the American Thyroid Association.

[85]  S. Polyzos,et al.  A Systematic Review of Cases Reporting Needle Tract Seeding Following Thyroid Fine Needle Biopsy , 2010, World Journal of Surgery.

[86]  S. Roman,et al.  Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment , 2010, Current opinion in oncology.

[87]  A. Colao,et al.  Predictive value of pentagastrin test for preoperative differential diagnosis between C‐cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels , 2009, Clinical endocrinology.

[88]  S. Roman,et al.  Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. , 2009, Surgery.

[89]  L. Cozzi,et al.  Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. , 2009, International journal of radiation oncology, biology, physics.

[90]  C. Sekulla,et al.  Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer. , 2009, Endocrine-related cancer.

[91]  H. Dralle,et al.  Postoperativer Zufallsbefund Schilddrüsenkarzinom: chirurgisches Konzept , 2009 .

[92]  H. Dralle,et al.  Chirurgie der Schilddrüsenkarzinome , 2009, Der Chirurg.

[93]  R. Kloos,et al.  Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[94]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[95]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[96]  N. Mikhaeel,et al.  Thyroid lymphoma and airway obstruction – is there a rationale for surgical management? , 2009, International journal of clinical practice.

[97]  Z. Baloch,et al.  The Many Faces of Follicular Variant of Papillary Thyroid Carcinoma , 2009 .

[98]  T. Lairmore,et al.  Routine bilateral central lymph node clearance for papillary thyroid cancer. , 2009, Surgery.

[99]  Z. Baloch,et al.  The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review. , 2009, Archives of pathology & laboratory medicine.

[100]  T. Fahey,et al.  Ipsilateral Versus Bilateral Central Neck Lymph Node Dissection in Papillary Thyroid Carcinoma , 2009, Annals of surgery.

[101]  L. Ceriani,et al.  99mTc‐sestamibi scanning in thyroid nodules with nondiagnostic cytology , 2009, Head & neck.

[102]  M. Luster,et al.  Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. , 2009, The Journal of clinical endocrinology and metabolism.

[103]  K. Lorenz,et al.  Individualization of Lymph Node Dissection in RET (Rearranged During Transfection) Carriers at Risk for Medullary Thyroid Cancer: Value of Pretherapeutic Calcitonin Levels , 2009, Annals of surgery.

[104]  R. Valcavi,et al.  Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. , 2009, Thyroid : official journal of the American Thyroid Association.

[105]  D. Steward,et al.  The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[106]  H. Gharib,et al.  Medullary thyroid cancer: management guidelines of the American Thyroid Association. , 2009, Thyroid : official journal of the American Thyroid Association.

[107]  H. Dralle,et al.  Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[108]  B. Niederle,et al.  Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region: A Prospectively Collected, Retrospectively Analyzed Clinical Trial , 2009, Annals of surgery.

[109]  E. Kulinskaya,et al.  Systematic review and meta‐analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone , 2009, The Laryngoscope.

[110]  S. Naing,et al.  Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence. , 2009, Thyroid : official journal of the American Thyroid Association.

[111]  Ricardo Rossi,et al.  An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. , 2009, The Journal of clinical endocrinology and metabolism.

[112]  M. Zimny,et al.  Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. , 2009, Thyroid : official journal of the American Thyroid Association.

[113]  Jee-Young Kim,et al.  Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection. , 2009, Thyroid : official journal of the American Thyroid Association.

[114]  Herb Chen,et al.  Contralateral papillary thyroid cancer: does size matter? , 2009, American journal of surgery.

[115]  A. Alavi,et al.  Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility , 2009, Acta radiologica.

[116]  Jandee Lee,et al.  Emergency dilation by self-expandable tracheal stent for upper airway obstruction in a patient with a giant primary thyroid lymphoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[117]  S. Hauptmann,et al.  Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. , 2009, Surgery.

[118]  H. Dralle,et al.  Zervikoviszerale Resektionen beim organüberschreitenden Schilddrüsenkarzinom , 2009, Der Chirurg.

[119]  H. Dralle,et al.  Surgical approaches in thyroid cancer and lymph-node metastases. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[120]  S. Hess,et al.  Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis. , 2008, Surgery.

[121]  L. Braverman,et al.  Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. , 2008, European journal of endocrinology.

[122]  D. Dazzi,et al.  Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or =2 cm. , 2008, Endocrine-related cancer.

[123]  O. Haas,et al.  Sporadic hypercalcitoninemia: clinical and therapeutic consequences. , 2008, Endocrine-related cancer.

[124]  K. Lorenz,et al.  [Hereditary thyroid cancer]. , 2008, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[125]  W. Oyen,et al.  Guidelines for radioiodine therapy of differentiated thyroid cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[126]  A. Agha,et al.  Thyroid metastases of renal cell carcinoma: clinical course in 45 patients undergoing surgery. Assessment of factors affecting patients' survival. , 2008, Thyroid : official journal of the American Thyroid Association.

[127]  S. Hauptmann,et al.  Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? , 2008, The Journal of clinical endocrinology and metabolism.

[128]  J. Califano,et al.  Consensus statement on the classification and terminology of neck dissection. , 2008, Archives of otolaryngology--head & neck surgery.

[129]  L. Skoog,et al.  Fine-Needle Aspiration Biopsy of Benign Thyroid Nodules: An Evidence-Based Review , 2008, World Journal of Surgery.

[130]  A. Pinchera,et al.  Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. , 2008, The Journal of clinical endocrinology and metabolism.

[131]  Nagesh Ragavendra,et al.  Evidence-Based Assessment of the Role of Ultrasonography in the Management of Benign Thyroid Nodules , 2008, World Journal of Surgery.

[132]  J. Roh,et al.  Prospective Identification of Chyle Leakage in Patients Undergoing Lateral Neck Dissection for Metastatic Thyroid Cancer , 2008, Annals of Surgical Oncology.

[133]  G. Antoch,et al.  Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[134]  J. Moley,et al.  Long-term Outcome of Reoperations for Medullary Thyroid Carcinoma , 2008, World Journal of Surgery.

[135]  C. Eisenberger,et al.  Long-Term Clinical and Biochemical Follow-up in Medullary Thyroid Carcinoma: A Single Institution's Experience Over 20 Years , 2007, Annals of surgery.

[136]  A. Miyauchi,et al.  Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck Dissection , 2007, World Journal of Surgery.

[137]  C. Ko,et al.  Extent of Surgery Affects Survival for Papillary Thyroid Cancer , 2007, Annals of surgery.

[138]  A. Proietti,et al.  Role of frozen section associated with intraoperative cytology in comparison to FNA and FS alone in the management of thyroid nodules. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[139]  M. Papotti,et al.  Poorly Differentiated Thyroid Carcinoma: The Turin Proposal for the Use of Uniform Diagnostic Criteria and an Algorithmic Diagnostic Approach , 2007, The American journal of surgical pathology.

[140]  S. Hauptmann,et al.  Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer , 2007, World Journal of Surgery.

[141]  H. Dralle,et al.  Inzidentalome der Schilddrüse , 2007, Der Chirurg.

[142]  Matthew C. Miller,et al.  Intraoperative pathologic examination: cost effectiveness and clinical value in patients with cytologic diagnosis of cellular follicular thyroid lesion. , 2007, Thyroid : official journal of the American Thyroid Association.

[143]  P. Miccoli,et al.  New trends in the treatment of undifferentiated carcinomas of the thyroid , 2007, Langenbeck's Archives of Surgery.

[144]  N. Mezzadri,et al.  Biochemical Results of Reoperations for Medullary Thyroid Carcinoma , 2007, The Laryngoscope.

[145]  J. Brierley,et al.  An evidence-based review of poorly differentiated thyroid cancer , 2007, World Journal of Surgery.

[146]  J. Moley,et al.  Evidence-based Approach to the Management of Sporadic Medullary Thyroid Carcinoma , 2007, World Journal of Surgery.

[147]  Tae Yong Kim,et al.  Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. , 2007, Endocrine journal.

[148]  Y. Nikiforov,et al.  Follicular variant papillary thyroid carcinoma arising within an ovarian teratoma. , 2007, Thyroid : official journal of the American Thyroid Association.

[149]  G. Doherty,et al.  Central Lymph Node Dissection in Differentiated Thyroid Cancer , 2007, World Journal of Surgery.

[150]  T. Carling,et al.  Special Variants of Differentiated Thyroid Cancer: Does It Alter the Extent of Surgery Versus Well-Differentiated Thyroid Cancer? , 2007, World Journal of Surgery.

[151]  C. McHenry.  Abnormal Carcinoembryonic Antigen Levels and Medullary Thyroid Cancer Progression—Invited Critique , 2007 .

[152]  G. Agarwal,et al.  Re: "The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy". , 2007, Surgery.

[153]  S. Hauptmann,et al.  Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. , 2007, Archives of surgery.

[154]  M. Maranghi,et al.  Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. , 2007, The Journal of clinical endocrinology and metabolism.

[155]  C. Hsueh,et al.  Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas , 2007, Clinical endocrinology.

[156]  J. Pasieka,et al.  An Evidence-Based Approach to the Treatment of Thyroid Lymphoma , 2007, World Journal of Surgery.

[157]  A. Miyauchi,et al.  Lateral and Mediastinal Lymph Node Dissection in Differentiated Thyroid Carcinoma: Indications, Benefits, and Risks , 2007, World Journal of Surgery.

[158]  S. Sidhu,et al.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. , 2006, Surgery.

[159]  K. Lorenz,et al.  Long-term results and functional outcome after cervical evisceration in patients with thyroid cancer. , 2006, Surgery.

[160]  H. Lai,et al.  Insular thyroid carcinoma: collective analysis of clinicohistologic prognostic factors and treatment effect with radioiodine or radiation therapy. , 2006, Journal of the American College of Surgeons.

[161]  L. Käser,et al.  Hodgkin-Lymphom (Morbus Hodgkin) , 2006 .

[162]  H. Goepfert,et al.  A prospective study of shoulder disability resulting from radical and modified neck dissections. , 2006, Head & neck surgery.

[163]  T. de Baère,et al.  Chemoembolization for liver metastases from medullary thyroid carcinoma. , 2006, The Journal of clinical endocrinology and metabolism.

[164]  W. Wiersinga,et al.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. , 2006, European journal of endocrinology.

[165]  P. Beck‐Peccoz,et al.  Normal Range of Calcitonin in Children Measured by a Chemiluminescent Two-Site Immunometric Assay , 2006, Hormone Research in Paediatrics.

[166]  K. Sugino,et al.  [Metastatic tumors of the thyroid]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[167]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[168]  J. Charboneau,et al.  Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. , 2006, Archives of surgery.

[169]  A. Shaha,et al.  Poorly differentiated and anaplastic thyroid cancer. , 2006, Cancer control : journal of the Moffitt Cancer Center.

[170]  Q. Duh,et al.  Selective Modified Radical Neck Dissection for Papillary Thyroid Cancer—Is Level I, II and V Dissection Always Necessary? , 2006, World Journal of Surgery.

[171]  J. Shah,et al.  Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis , 2006, Cancer.

[172]  N. D. Charkes,et al.  On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. , 2006, Thyroid : official journal of the American Thyroid Association.

[173]  G. Randolph,et al.  The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. , 2006, Surgery.

[174]  K. Schmid,et al.  How to define follicular thyroid carcinoma? , 2006, Virchows Archiv.

[175]  M. Hočevar,et al.  Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.

[176]  Robin A. Samlan,et al.  The Utility of Evaluating True Vocal Fold Motion Before Thyroid Surgery , 2006, The Laryngoscope.

[177]  A. Miyauchi,et al.  Prognostic Significance of Extrathyroid Extension of Papillary Thyroid Carcinoma: Massive but Not Minimal Extension Affects the Relapse-free Survival , 2006, World Journal of Surgery.

[178]  A. Miyauchi,et al.  Minimal Extrathyroid Extension Does Not Affect the Relapse-Free Survival of Patients with Papillary Thyroid Carcinoma Measuring 4 cm or Less over the Age of 45 Years , 2005, Surgery Today.

[179]  S. Baumgartner-Parzer,et al.  Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. , 2005, Thyroid : official journal of the American Thyroid Association.

[180]  R. Jeffrey,et al.  Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. , 2005, Ultrasound quarterly.

[181]  J. Jimeno,et al.  Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. , 2005, Surgery.

[182]  C. Sekulla,et al.  Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma. , 2005, Surgery.

[183]  F. Kraeber-Bodéré,et al.  Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. , 2005, The Journal of clinical endocrinology and metabolism.

[184]  K. Owzar,et al.  Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.

[185]  T. Carling,et al.  Follicular neoplasms of the thyroid: what to recommend. , 2005, Thyroid : official journal of the American Thyroid Association.

[186]  H. Lehnert,et al.  Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. , 2005, The Journal of clinical endocrinology and metabolism.

[187]  A. Miyauchi,et al.  Ultrasonographically and Anatomopathologically Detectable Node Metastases in the Lateral Compartment as Indicators of Worse Relapse-free Survival in Patients with Papillary Thyroid Carcinoma , 2005, World Journal of Surgery.

[188]  M. Xing,et al.  BRAF mutation in thyroid cancer. , 2005, Endocrine-related cancer.

[189]  G. Nguyen,et al.  Metastatic melanoma of the thyroid mimicking a papillary carcinoma in fine‐needle aspiration , 2005, Diagnostic cytopathology.

[190]  R. Paschke,et al.  Iodine nutrition, nodular thyroid disease, and urinary iodine excretion in a German university study population. , 2005, Thyroid : official journal of the American Thyroid Association.

[191]  H. Holzhausen,et al.  Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. , 2005, The Journal of clinical endocrinology and metabolism.

[192]  E. Baudin,et al.  Follicular Cell-Derived Thyroid Cancer in Children , 2005, Hormone Research in Paediatrics.

[193]  E. Kebebew,et al.  Anaplastic thyroid carcinoma , 2005, Cancer.

[194]  Tae Yong Kim,et al.  Metastasis to the thyroid diagnosed by fine‐needle aspiration biopsy , 2005, Clinical endocrinology.

[195]  K. Kaczirek,et al.  Importance of tumour size in papillary and follicular thyroid cancer , 2005, The British journal of surgery.

[196]  J. Le Néel,et al.  Management and prognosis of metastases to the thyroid gland. , 2005, Journal of the American College of Surgeons.

[197]  Jeffrey E. Lee,et al.  Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. , 2004, Surgery.

[198]  Q. Duh,et al.  Prognostic Indications for Hürthle Cell Cancer , 2004, World Journal of Surgery.

[199]  C. Sekulla,et al.  Multiple Endocrine Neoplasia 2B Syndrome due to Codon 918 Mutation: Clinical Manifestation and Course in Early and Late Onset Disease , 2004, World Journal of Surgery.

[200]  E. Mallet,et al.  Reference intervals for serum calcitonin in men, women, and children. , 2004, Clinical chemistry.

[201]  J. Kapelushnik,et al.  Thyroglossal duct carcinoma in children: case presentation and review of the literature. , 2004, Thyroid : official journal of the American Thyroid Association.

[202]  L. Hurtado-López,et al.  Thyroglossal duct cyst with papillary carcinoma: what must be done? , 2004, Thyroid : official journal of the American Thyroid Association.

[203]  J. Cuisenier,et al.  Les métastases intrathyroïdiennes du cancer du rein à cellules claires : présentation de sept cas et revue de la littérature , 2004 .

[204]  J. Roodenburg,et al.  Shoulder complaints after nerve sparing neck dissections. , 2004, International journal of oral and maxillofacial surgery.

[205]  Jen-Der Lin,et al.  Insular Carcinoma: Infrequent Subtype of Thyroid Cancer with Aggressive Clinical Course , 2004, World Journal of Surgery.

[206]  H. Röher,et al.  Incidentally Found Medullary Thyroid Cancer: Treatment Rationale for Small Tumors , 2004, World Journal of Surgery.

[207]  S. Mandel,et al.  Safety of Modified Radical Neck Dissection for Differentiated Thyroid Carcinoma , 2004, The Laryngoscope.

[208]  M. Papotti,et al.  Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns , 2004, Cancer.

[209]  Bruno D Fornage,et al.  Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. , 2003, Surgery.

[210]  R. Tsang,et al.  Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[211]  H. Dralle,et al.  Early malignant progression of hereditary medullary thyroid cancer. , 2003, The New England journal of medicine.

[212]  S. Mandel,et al.  Role of repeat fine‐needle aspiration biopsy (FNAB) in the management of thyroid nodules , 2003, Diagnostic cytopathology.

[213]  M. Carcangiu.  Hürthle Cell Carcinoma: Clinic-Pathological and Biological Aspects , 2003, Tumori.

[214]  K. Schmid,et al.  Tumoren der Schilddrüse , 2003, Der Pathologe.

[215]  H. Holzhausen,et al.  Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma , 2003, Cancer.

[216]  J. Buckner,et al.  Management of brain metastases from thyroid carcinoma , 2003, Cancer.

[217]  E. Baudin,et al.  Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. , 2003, The Journal of clinical endocrinology and metabolism.

[218]  N. Ordóñez,et al.  Prognostic factors in patients with Hürthle cell neoplasms of the thyroid , 2003, Cancer.

[219]  Koichi Ito,et al.  Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas: Frequency, Pattern of Occurrence and Recurrence, and Optimal Strategy for Neck Dissection , 2003, Annals of surgery.

[220]  Ajay Mahaputra Kumar,et al.  Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer , 2003, Nuclear medicine communications.

[221]  L. Hegedüs,et al.  Management of simple nodular goiter: current status and future perspectives. , 2003, Endocrine reviews.

[222]  Herb Chen,et al.  Palliative thyroidectomy for malignant lymphoma of the thyroid , 2002, Annals of Surgical Oncology.

[223]  B. Wenig,et al.  Metastatic renal cell carcinoma to the thyroid gland , 2002, Cancer.

[224]  B. Barraclough,et al.  Minimally invasive follicular thyroid carcinoma: Completion thyroidectomy or not? , 2002, ANZ journal of surgery.

[225]  G. Daniels,et al.  Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid. , 2002, Thyroid : official journal of the American Thyroid Association.

[226]  L. Grimelius,et al.  Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery , 2002, British Journal of Cancer.

[227]  A. Miyauchi,et al.  Prospective Trial of Unilateral Surgery for Nonhereditary Medullary Thyroid Carcinoma in Patients without Germline RET Mutations , 2002, World Journal of Surgery.

[228]  Anna Crescenzi,et al.  Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. , 2002, The Journal of clinical endocrinology and metabolism.

[229]  T. Junginger,et al.  Beeinflusst der Zeitpunkt der Restthyreoidektomie die Prognose differenzierter Schilddrüsenkarzinome , 2002 .

[230]  Kunihiko Ito,et al.  The important role of operations in the management of anaplastic thyroid carcinoma. , 2002, Surgery.

[231]  G. Zettinig,et al.  Long‐term follow‐up of patients with bone metastases from differentiated thyroid carcinoma – surgery or conventional therapy? , 2002, Clinical endocrinology.

[232]  S. Takao,et al.  Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. , 2002, Surgery.

[233]  R. Görges,et al.  Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma , 2001, Annals of surgery.

[234]  B. Ponder,et al.  Guidelines for diagnosis and therapy of MEN type 1 and type 2. , 2001, The Journal of clinical endocrinology and metabolism.

[235]  T. Schilling,et al.  Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. , 2001, Surgery.

[236]  G. Thompson,et al.  Anaplastic thyroid carcinoma: a 50-year experience at a single institution. , 2001, Surgery.

[237]  John P. Bilezikian,et al.  CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .

[238]  S. Bardet,et al.  Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma , 2001, Clinical endocrinology.

[239]  R. Hinze,et al.  Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. , 2001, Archives of surgery.

[240]  J. Quivey,et al.  Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival , 2001, Cancer.

[241]  W. Westra,et al.  Randomized Prospective Evaluation of Frozen-Section Analysis for Follicular Neoplasms of the Thyroid , 2001, Annals of surgery.

[242]  G. Hejblum,et al.  Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. , 2001, The Journal of clinical endocrinology and metabolism.

[243]  R. Golouh,et al.  Effect of primary treatment on survival in anaplastic thyroid carcinoma. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[244]  M. Schwab,et al.  Prognostic value of codon 918 (ATG→ACG) RET proto‐oncogene mutations in sporadic medullary thyroid carcinoma , 2001, International journal of cancer.

[245]  R. Hinze,et al.  Hypercalcitoninemia in a Sporadic Asymptomatic Neuroendocrine Tumor of the Pancreatic Tail , 2000, Digestive Surgery.

[246]  J. Klempnauer,et al.  Familial Papillary Thyroid Carcinoma: Genetics, Criteria for Diagnosis, Clinical Features, and Surgical Treatment , 2000, World Journal of Surgery.

[247]  R. Demay.  Follicular lesions of the thyroid. W(h)ither follicular carcinoma? , 2000, American journal of clinical pathology.

[248]  H. Holzhausen,et al.  Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation , 2000, Langenbeck's Archives of Surgery.

[249]  S. Blaugrund,et al.  Follicular Variant of Papillary Carcinoma: The Diagnostic Limitations of Preoperative Fine‐Needle Aspiration and Intraoperative Frozen Section Evaluation , 2000, The Laryngoscope.

[250]  Q. Duh,et al.  Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. , 2000, Archives of surgery.

[251]  J. Shah,et al.  Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 , 2000, Cancer.

[252]  L. Thompson,et al.  Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. , 2000, The American journal of surgical pathology.

[253]  K. Lam,et al.  Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. , 2000, Annals of surgery.

[254]  H. Heshmati,et al.  Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). , 2000, The Journal of clinical endocrinology and metabolism.

[255]  C. Reiners,et al.  Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid? , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[256]  A. Kaider,et al.  Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. , 1999, Surgery.

[257]  J. Klempnauer,et al.  Invasive differentiated thyroid carcinoma: tracheal resection and reconstruction procedures in the hands of the endocrine surgeon. , 1999, Surgery.

[258]  M. Bouvet,et al.  Surgical strategy for the treatment of medullary thyroid carcinoma. , 1999, Annals of surgery.

[259]  J. Moley,et al.  Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. , 1999, Annals of surgery.

[260]  M. Sack,et al.  Papillary formations in metastatic melanoma , 1999, Diagnostic cytopathology.

[261]  P. Schultz,et al.  Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long‐term follow‐up , 1998, Head & neck.

[262]  R. Hinze,et al.  Prophylactic Thyroidectomy in 75 Children and Adolescents with Hereditary Medullary Thyroid Carcinoma: German and Austrian Experience , 1998, World Journal of Surgery.

[263]  C. Eng,et al.  Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine. , 1998, The Journal of clinical endocrinology and metabolism.

[264]  H. Dralle,et al.  Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? , 1997, Surgery.

[265]  S. Sherman,et al.  Prognosis and treatment of brain metastases in thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.

[266]  O. Schober,et al.  Survival of differentiated thyroid carcinoma studied in 500 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[267]  Q. Duh,et al.  Textbook of Endocrine Surgery , 1997 .

[268]  H. Hundeshagen,et al.  Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. , 1996, The European journal of surgery = Acta chirurgica.

[269]  H. Dralle,et al.  Lymphadenektomie beim Schilddrüsencarcinom , 1996, Der Chirurg.

[270]  Herb Chen,et al.  Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? , 1995, Annals of surgery.

[271]  J H Lubin,et al.  Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. , 1995, Radiation research.

[272]  T. van Vroonhoven,et al.  Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. , 1994, The New England journal of medicine.

[273]  J. Ivanovich,et al.  Predictive DNA Testing and Prophylactic Thyroidectomy in Patients at Risk for Multiple Endocrine Neoplasia Type 2A , 1994, Annals of surgery.

[274]  H. Hundeshagen,et al.  Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer , 1994, World Journal of Surgery.

[275]  P. Goodfellow,et al.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. , 1993, Human molecular genetics.

[276]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[277]  E. Bergstralh,et al.  Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. , 1992, Surgery.

[278]  H. Dralle,et al.  [Cervical interventions on the airway and esophagus in infiltrating thyroid cancer]. , 1992, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[279]  A. Lawrence,et al.  Anaplastic thyroid carcinoma: risk factors and outcome. , 1991, Surgery.

[280]  H. Gharib,et al.  Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. , 1990, Annals of surgery.

[281]  I. Hay,et al.  Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. , 1988, Surgery.

[282]  A. Miyauchi,et al.  Evaluation of surgical results and prediction of prognosis in patients with medullary thyroid carcinoma by analysis of serum calcitonin levels , 1988, World Journal of Surgery.

[283]  C. Wittekind,et al.  TNM Klassifikation maligner Tumoren , 1987 .

[284]  C. Bürk,et al.  Metastasen in der Schilddrüse -Morphologie und Klinik von 25 sekundären Schilddrüsengeschwülsten , 1987, Langenbecks Archiv für Chirurgie.

[285]  L. Woolner,et al.  Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1986, Mayo Clinic proceedings.

[286]  W. Farrar,et al.  Clinical and pathologic correlations in disease metastatic to the thyroid gland. , 1985, American journal of surgery.

[287]  J. Rosai,et al.  Poorly differentiated (“insular”) thyroid carcinoma: A reinterpretation of Langhans' “wuchernde Struma” , 1984, The American journal of surgical pathology.

[288]  A. Miyauchi,et al.  Relation of Doubling Time of Plasma Calcitonin Levels to Prognosis and Recurrence of Medullary Thyroid Carcinoma , 1984, Annals of surgery.

[289]  Brady Lw,et al.  Unusual sites of metastases. , 1977 .

[290]  T. Berge,et al.  [Cancer in Malmö 1958-66]. , 1970, Lakartidningen.

[291]  J. Sokal,et al.  Metastatic neoplasms in the thyroid gland. Pathological and clinical findings , 1962, Cancer.

[292]  L. Woolner,et al.  Secondary malignant tumors of the thyroid gland , 1956, Cancer.

[293]  L. Bastholt,et al.  2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer , 2012, European Thyroid Journal.

[294]  A. Machens,et al.  Primary surgery for differentiated thyroid cancer in the new millennium. , 2012, Journal of endocrinological investigation.

[295]  T. Fahey.  Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases , 2011 .

[296]  H. Dralle,et al.  Outcome after thyroid surgery for metastasis from renal cell cancer. , 2010, Surgery.

[297]  Yasuhiro Ito,et al.  Therapeutic Strategy for Differentiated Thyroid Carcinoma in Japan Based on a Newly Established Guideline Managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons , 2010, World Journal of Surgery.

[298]  A. Chambers,et al.  Poorly Differentiated and Undifferentiated Thyroid Cancer , 2009 .

[299]  M. Dietlein,et al.  MIBI scintigraphy in hypofunctioning thyroid nodules , 2009, Nuklearmedizin.

[300]  E. Baudin,et al.  Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. , 2009, The Journal of clinical endocrinology and metabolism.

[301]  M. Dietlein,et al.  MIBI-Szintigraphie kalter Schilddrüsenknoten – Kann sie die Dignität kalter Knoten vorhersagen? , 2009 .

[302]  K. Rahbar,et al.  Risk-profile and outcome of small papillary and follicular thyroid carcinomas (≤1 cm) , 2008, Nuklearmedizin.

[303]  H. Dralle,et al.  Hereditäre Schilddrüsenkarzinome , 2008, Der Chirurg.

[304]  H. Dralle,et al.  Prediction of Mediastinal Lymph Node Metastasis in Papillary Thyroid Cancer , 2008, Annals of Surgical Oncology.

[305]  B. Ms,et al.  Surgical Options in Undifferentiated Thyroid Carcinoma , 2007, World Journal of Surgery.

[306]  O. Schober,et al.  Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer , 2007, Nuklearmedizin.

[307]  O. Schober,et al.  Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3) , 2007, Nuklearmedizin.

[308]  M. Caligiuri,et al.  Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

[309]  H. Dralle,et al.  Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma , 2006, Surgery Today.

[310]  J. Rosai.  Handling of thyroid follicular patterned lesions , 2005, Endocrine pathology.

[311]  A. Bockisch,et al.  124I Positron Emission Tomographic Dosimetry and Positron Emission Tomography/Computed Tomography Imaging in Differentiated Thyroid Cancer , 2005 .

[312]  H. Dralle,et al.  Chapter 34 – Surgical Management of Advanced Thyroid Cancer Invading the Aerodigestive Tract , 2005 .

[313]  D. Fraker,et al.  Chapter 26 – Factors That Predispose to Thyroid Neoplasia , 2005 .

[314]  G. Brabant,et al.  Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. , 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[315]  A. Georgii,et al.  The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland , 2004, Virchows Archiv A.

[316]  H. Holzhausen,et al.  Skip metastases in thyroid cancer leaping the central lymph node compartment. , 2004, Archives of surgery.

[317]  N. Wada,et al.  Solitary Metachronous Metastasis to the Thyroid from Renal Clear Cell Carcinoma 19 Years After Nephrectomy: Report of a Case , 2004, Surgery Today.

[318]  A. Pinchera,et al.  Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. , 2004, The Journal of clinical endocrinology and metabolism.

[319]  H. Dralle,et al.  Die transsternale zervikomediastinale Primärtumorresektion und Lymphadenektomie beim Schilddrüsenkarzinom , 2004, Langenbecks Archiv für Chirurgie.

[320]  G. Salles,et al.  Primary thyroid lymphoma is a heterogeneous disease. , 2002, The Journal of clinical endocrinology and metabolism.

[321]  A. Muzikansky,et al.  The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma , 2002, Annals of Surgical Oncology.

[322]  R. Hinze,et al.  Pattern of Nodal Metastasis for Primary and Reoperative Thyroid Cancer , 2001, World Journal of Surgery.

[323]  C. Reiners,et al.  Thyroid Cancer in Chernobyl Children , 2001 .

[324]  K. Lam,et al.  Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. , 1998, Archives of pathology & laboratory medicine.

[325]  H. Gharib,et al.  Metastasis to the thyroid gland. A report of 43 cases. , 1997, Cancer.

[326]  E. Oberhausen,et al.  Granulocyte Labelling Kit BW 250/183 , 1996, Nuklearmedizin.

[327]  T. Greiner,et al.  Non-Hodgkin's lymphoma. , 2016, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[328]  P. Wollan,et al.  Immunohistochemical analysis of the cell cycle-associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas , 1995, Endocrine pathology.

[329]  R. Laing,et al.  The significance of MALT histology in thyroid lymphoma: a review of patients from the BNLI and Royal Marsden Hospital. , 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

[330]  P. Bunn,et al.  Secondary malignancy of the thyroid gland: a case report and review of the literature. , 1994, Thyroid : official journal of the American Thyroid Association.

[331]  J. Magner,et al.  Urticaria due to blue dye in synthroid tablets. , 1994, Thyroid : official journal of the American Thyroid Association.

[332]  I. Narabayashi,et al.  Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. , 1993, Thyroid : official journal of the American Thyroid Association.

[333]  E. Bergstralh,et al.  Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1991, Mayo Clinic proceedings.

[334]  S. Jansson,et al.  Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. , 1986, Surgery.

[335]  L. Brady,et al.  Unusual sites of metastases. , 1977, Seminars in oncology.

[336]  T. Berge,et al.  Cancer in Malmö 1958-1969. An autopsy study. , 1977, Acta pathologica et microbiologica Scandinavica. Supplement.

[337]  W. Wachsmuth,et al.  Lanz / Wachsmuth Praktische Anatomie. Hals , 1955 .

[338]  MIBI scintigraphy in hypo - functioning thyroid nodules Can it predict the dignity of the lesion? , 2022 .